Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 12/01 07:12:43 am
133.725 EUR   -0.09%
02:45aMERCK : to Accelerate Commercialization of OLED Display Materials Through Partnerships
DJ
11/30MERCK KGAA : Gets a Buy rating from Kepler Cheuvreux
MD
11/26MERCK : Partners With Siemens on New Plant
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Merck : to Invest EUR18 Million in Swiss Laboratory

07/15/2020 | 10:00am EST

By Cecilia Butini

Merck KGaA said Wednesday that it plans to spend 18 million euros ($20.5 million) to build a new laboratory in Buchs, Switzerland, to expand its reference-materials business and its research-and-development sector.

The German pharmaceutical, chemical and life-sciences company said the expansion will create about two dozen new jobs. The laboratory will be finished by the end of 2021 and 40 employees will move into the building at the beginning of 2022, the company said.

According to Merck, the facility will add to an existing production hub in Buchs, where the company already produces reference materials and bioanalytical reagents, among other products, employing 450 people.

 

Write to Cecilia Butini at cecilia.butini@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
BIOANALYTICAL SYSTEMS, INC. 1.54% 6.58 Delayed Quote.32.93%
MERCK KGAA 0.11% 133.55 Delayed Quote.27.05%
All news about MERCK KGAA
02:45aMERCK : to Accelerate Commercialization of OLED Display Materials Through Partne..
DJ
11/30MERCK KGAA : Gets a Buy rating from Kepler Cheuvreux
MD
11/26MERCK : Partners With Siemens on New Plant
DJ
11/24Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
11/24MERCK KGAA : Correction of a release from 25/03/2020 according to Article 40, Se..
EQ
11/23MERCK : Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named t..
AQ
11/23MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
11/19MERCK : EMD Serono's Embracing Carers Announces Study Results on COVID-19 and Ca..
AQ
11/17MERCK KGAA : UBS reiterates its Neutral rating
MD
11/16MERCK KGAA : Goldman Sachs keeps a Sell rating
MD
More news
Financials
Sales 2020 17 381 M 20 812 M 20 812 M
Net income 2020 2 013 M 2 410 M 2 410 M
Net Debt 2020 11 224 M 13 440 M 13 440 M
P/E ratio 2020 28,7x
Yield 2020 1,05%
Capitalization 58 195 M 69 553 M 69 683 M
EV / Sales 2020 3,99x
EV / Sales 2021 3,71x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 135,37 €
Last Close Price 133,85 €
Spread / Highest target 26,3%
Spread / Average Target 1,13%
Spread / Lowest Target -24,5%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA27.05%69 553
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD90.24%19 173
KYOWA KIRIN CO., LTD.10.18%14 594
BETTA PHARMACEUTICALS CO., LTD.38.95%5 594
YUHAN CORPORATION36.15%3 641
RECIPHARM AB (PUBL)29.21%1 996